Toxicology – Activated Charcoal

Core Concept

Activated charcoal is a gastrointestinal decontamination agent that adsorbs many drugs and chemicals within the GI tract, reducing the amount available for systemic absorption.

It can be used in two distinct ways:

• Single-dose activated charcoal (SDAC) → attempts to reduce absorption after selected acute ingestions.
• Multiple-dose activated charcoal (MDAC) → enhances elimination of a small group of toxins after absorption.

Activated charcoal is not routinely indicated for every overdose.

Adsorption, Not Absorption

Activated charcoal works by adsorption.

This means toxic molecules attach to the charcoal’s enormous porous surface rather than being absorbed into the charcoal itself.

The resulting:

Charcoal–toxin complex → remains within GI tract → passes through stool

This decreases gastrointestinal availability of the toxin.

Why Activated Charcoal Works

Activated charcoal is specially processed to create:

• Extensive microscopic pores
• Very large surface area
• Numerous binding sites for organic molecules

Binding is strongest for many relatively large, nonpolar or poorly water-soluble organic compounds.

Small, highly ionized substances are generally less effectively adsorbed.

Single-Dose Activated Charcoal

The purpose of SDAC is to:

Bind toxin still present in the GI tract → reduce subsequent systemic absorption

It is most useful when:

• The ingestion is potentially clinically important.
• The substance is well adsorbed by charcoal.
• Administration occurs reasonably soon after ingestion.
• The patient’s airway is safe.

The potential benefit generally decreases as time passes because progressively more toxin has already been absorbed.

Timing

Activated charcoal provides its greatest theoretical benefit when given early after ingestion, particularly within approximately the first hour.

However, time alone should not determine its use.

Later administration may occasionally be considered when absorption is delayed, such as with:

• Extended-release preparations
• Enteric-coated products
• Drugs that slow gastrointestinal motility
• Very large ingestions
• Substances capable of forming pharmacobezoars

Therefore:

Charcoal should be selected according to the toxicant, formulation, timing, clinical condition, and aspiration risk—not simply because an overdose occurred.

Substances Commonly Adsorbed

Activated charcoal adsorbs many clinically important drugs, including various:

• Antidepressants
• Antipsychotics
• Anticonvulsants
• Acetaminophen
• Salicylates
• Theophylline
• Cardiovascular medications
• Sedative medications
• Antihistamines

However, charcoal adsorption varies between substances.

Important Substances Poorly Adsorbed

A useful mnemonic is:

PHAILS

• P – Pesticides? (not a reliable component of the mnemonic because many organic pesticides can actually bind charcoal)
• H – Hydrocarbons
• A – Alcohols
• I – Iron
• L – Lithium
• S – Strong acids/alkalis

A more reliable approach is to remember the major groups directly.

Activated charcoal is generally ineffective or inappropriate for:

• Lithium
• Iron
• Potassium
• Methanol
• Ethylene glycol
• Ethanol
• Isopropanol
• Strong acids
• Strong alkalis
• Many simple inorganic ions

These substances are either poorly adsorbed or present other reasons why charcoal is inappropriate.

Toxic Alcohols

Activated charcoal has essentially no useful role for:

• Methanol
• Ethylene glycol
• Isopropanol
• Ethanol

These small alcohol molecules are poorly adsorbed and are rapidly absorbed.

Management instead depends on the particular alcohol and may involve:

• Supportive care
• Fomepizole for methanol/ethylene glycol
• Correction of metabolic abnormalities
• Hemodialysis in selected severe cases

Iron

Activated charcoal does not effectively adsorb iron.

Therefore, charcoal should not be relied upon after significant iron ingestion.

Selected severe iron ingestions may instead require:

• Supportive management
• Whole-bowel irrigation in appropriate circumstances
• Deferoxamine for significant systemic toxicity

Lithium

Lithium is a small ion and is poorly adsorbed by charcoal.

Activated charcoal therefore has no meaningful role for an isolated lithium ingestion.

However, if a mixed overdose contains lithium plus another charcoal-adsorbable drug, charcoal may potentially benefit the other substance, not the lithium.

Caustic Ingestion

Activated charcoal is generally inappropriate after strong acid or alkali ingestion.

Reasons include:

• Poor therapeutic benefit
• Vomiting/aspiration risk
• Potential interference with endoscopic evaluation
• Failure to prevent direct tissue injury

Management emphasizes airway assessment, supportive care, and appropriate evaluation of caustic injury.

Hydrocarbon Ingestion

Charcoal is generally avoided after isolated hydrocarbon ingestion.

The major danger is often:

Aspiration → chemical pneumonitis

Charcoal adds aspiration risk while offering limited clinical benefit for many hydrocarbons.

Airway Protection

The most important safety consideration is aspiration.

Activated charcoal should generally not be administered to a patient who cannot reliably protect their airway unless the airway has already been secured for independent clinical reasons.

High-risk findings include:

• Significant CNS depression
• Recurrent seizures
• Severe agitation
• Repeated vomiting
• Loss of protective airway reflexes

Charcoal aspiration can produce severe pulmonary injury.

Important Airway Principle

Do not intubate a patient solely to administer activated charcoal unless the overall clinical situation independently justifies airway control.

The potential benefit of charcoal must outweigh the risks of both the procedure and aspiration.

Contraindications and Situations to Avoid Charcoal

Activated charcoal should generally be avoided or used only after specialist consideration when there is:

• Unprotected airway
• High aspiration risk
• Gastrointestinal obstruction
• Ileus
• Suspected GI perforation
• Significant caustic ingestion
• Isolated hydrocarbon ingestion with substantial aspiration potential
• A substance known not to bind meaningfully to charcoal

MDAC particularly requires adequate gastrointestinal motility.

Adverse Effects

The most common problems are gastrointestinal.

Possible adverse effects include:

• Nausea
• Vomiting
• Constipation
• Abdominal distension

Less common but serious complications include:

• Aspiration pneumonitis
• Airway obstruction from aspirated charcoal
• Ileus
• Charcoal bezoar
• Bowel obstruction
• Rare gastrointestinal perforation

Risk increases when repeated doses are used or GI motility is impaired.

Charcoal Aspiration

Pulmonary aspiration is the most clinically important complication.

It may cause:

• Hypoxemia
• Pneumonitis
• Airway obstruction
• Severe respiratory failure

The risk-benefit assessment should therefore occur before charcoal administration, not after the patient becomes sedated or develops seizures.

Cathartics

Older practice commonly combined charcoal with:

• Sorbitol
• Magnesium-containing cathartics
• Other laxatives

Routine cathartic administration is no longer recommended.

They have not demonstrated meaningful improvement in poisoning outcomes and may cause:

• Diarrhea
• Dehydration
• Electrolyte abnormalities

Repeated cathartic administration is particularly inappropriate.

Multiple-Dose Activated Charcoal

MDAC differs fundamentally from a second dose given simply because gastrointestinal absorption is prolonged.

The purpose of true MDAC is to:

Increase systemic elimination of selected toxins

It may work by:

• Interrupting enterohepatic recirculation
• Binding drug secreted into the intestinal lumen
• Maintaining a concentration gradient that promotes movement of drug from blood toward the gastrointestinal tract

This phenomenon is sometimes described as gastrointestinal dialysis.

Classic MDAC Drugs

The major substances for which MDAC has an established toxicokinetic role can be remembered as:

ABCD

• A – not traditionally included
• B – Barbiturates, especially phenobarbital
• C – Carbamazepine
• D – Dapsone

And importantly:

• Quinine
• Theophylline

A practical high-yield list is therefore:

Carbamazepine – Dapsone – Phenobarbital – Quinine – Theophylline

Phenobarbital

MDAC can increase phenobarbital elimination.

It may be considered in significant poisoning when:

• Toxicity is substantial
• GI motility is adequate
• The airway is protected
• The anticipated benefit outweighs aspiration and GI risks

Carbamazepine

Carbamazepine is particularly relevant because large overdoses can cause:

• Delayed absorption
• CNS depression
• Seizures
• Anticholinergic effects
• QRS widening
• Dysrhythmias

MDAC can enhance elimination in significant poisoning.

Severe poisoning may additionally require extracorporeal treatment in selected circumstances.

Dapsone

Dapsone can produce:

• Methemoglobinemia
• Hemolysis
• Recurrent toxicity

Its metabolites undergo enterohepatic circulation.

MDAC can help interrupt this recycling and may be useful in significant poisoning.

Theophylline

MDAC can substantially increase theophylline elimination.

Severe theophylline poisoning may produce:

• Persistent vomiting
• Tachycardia
• Hypokalemia
• Hyperglycemia
• Seizures
• Dysrhythmias

Extracorporeal removal may also be required in severe cases.

Quinine

MDAC can increase quinine elimination.

Quinine toxicity may produce:

• Tinnitus
• Hearing abnormalities
• Visual disturbances
• Hypotension
• Dysrhythmias

Its use must still be balanced against the risks of repeated charcoal administration.

Not Every Extended-Release Ingestion Needs MDAC

This distinction is important.

A later or additional charcoal dose intended to capture drug that is still being absorbed is not necessarily the same as MDAC used for enhanced systemic elimination.

Extended-release formulations may sometimes justify additional GI decontamination strategies, but this depends on:

• Drug involved
• Amount
• Timing
• GI function
• Clinical course

Whole-bowel irrigation may sometimes be considered instead for selected extended-release or poorly charcoal-adsorbed substances.

Drug Interactions

Activated charcoal can adsorb medications administered orally.

This includes:

• Therapeutic drugs
• Oral antidotes
• Other necessary medications

MDAC may also increase elimination of some medications already present systemically.

Therefore, medication timing and route should be considered when charcoal is being used.

Pregnancy

Activated charcoal is not systemically absorbed in meaningful amounts.

Pregnancy itself is therefore not generally considered a contraindication when charcoal is otherwise clinically indicated.

The same fundamental risk-benefit assessment applies, particularly regarding:

• Aspiration
• Maternal stability
• Toxicant severity

Children

Children can receive activated charcoal when genuinely indicated, but particular attention should be given to:

• Aspiration risk
• Ability to cooperate
• Vomiting
• Airway size
• Fluid/electrolyte complications from inappropriate cathartic use

Routine charcoal after every pediatric ingestion is not appropriate.

Older Adults

Older patients may have:

• Reduced GI motility
• Greater aspiration risk
• Multiple medications
• Increased susceptibility to bowel complications

MDAC can also interfere with or increase elimination of necessary therapeutic medications.

Monitoring During Charcoal Therapy

Monitor for:

• Vomiting
• Abdominal distension
• Bowel function
• Respiratory deterioration
• Aspiration
• Mental-status changes

During MDAC, reassess whether:

• GI motility remains adequate
• Toxicity is improving
• Continued charcoal remains beneficial
• Complications are developing

When to Stop MDAC

There is no universal fixed duration appropriate for every poisoning.

Treatment should be individualized according to:

• Clinical improvement
• Toxicant concentrations when useful
• Expected toxicokinetics
• GI function
• Development of complications
• Availability of more effective elimination methods

Activated Charcoal vs Whole-Bowel Irrigation

These techniques work differently.

Activated Charcoal

Adsorbs selected chemicals.

Whole-Bowel Irrigation

Physically moves gastrointestinal contents through the bowel.

Whole-bowel irrigation may be considered for selected situations such as:

• Certain sustained-release preparations
• Iron
• Lithium
• Drug packets

The appropriate method depends on the substance and clinical situation.

Activated Charcoal vs Hemodialysis

Charcoal primarily acts within the gastrointestinal tract.

Hemodialysis removes suitable toxins from the bloodstream.

Some severe poisonings may involve both gastrointestinal decontamination and extracorporeal elimination, depending on the toxicant and timing.

Important Modernization of the Older Source

Several recommendations in the original material reflect older toxicology practice.

Modern management does not support:

• Giving charcoal routinely for nearly every poisoning
• Automatically giving charcoal merely because symptoms are present late after ingestion
• Routine cathartics with the first dose
• Repeated cathartic administration
• Automatic redosing after vomiting
• Routine repeated charcoal for broad categories of overdoses
• Fixed MDAC schedules without individualized reassessment

Current practice uses activated charcoal selectively, based on anticipated benefit versus aspiration and gastrointestinal risk.

Key Points

• Activated charcoal adsorbs many drugs in the GI tract and reduces their availability for absorption.
• It is most useful when given relatively early after a clinically important, charcoal-adsorbable ingestion.
• Benefit generally declines as time from ingestion increases.
• Delayed absorption may occasionally justify later consideration.
• Charcoal does not effectively adsorb lithium, iron, potassium, or toxic alcohols.
• It is generally inappropriate for strong caustics and isolated hydrocarbon exposures.
• The major complication is pulmonary aspiration.
• An unprotected airway with impaired consciousness is a major contraindication.
• Routine cathartics are no longer recommended.
• MDAC is used for enhanced elimination, not simply because an overdose is severe.
• High-yield MDAC substances are carbamazepine, dapsone, phenobarbital, quinine, and theophylline.
• MDAC should not be used when significant ileus or bowel obstruction is present.
• Activated charcoal can adsorb orally administered therapeutic medications and antidotes.
• Whole-bowel irrigation and hemodialysis are fundamentally different techniques and may be preferable for particular toxins.
• Modern toxicology favors selective charcoal use based on toxicant, timing, formulation, airway safety, GI function, and expected clinical benefit rather than routine administration.